Mobile App

Google Play Apple Store
PrEP in Clinical Practice - Updated 9/17/18
Certified CME/CNE Activity - Mini Modules
A number of organizations have recommended the use of PrEP to people at greatest risk of HIV acquisition. However there remains a significant gap between proving efficacy in clinical trials and achieving effectiveness in the real-world setting. Although clinical trial data provide an initial framework for the efficacy and safety of PrEP, a number of questions and concerns remain about how to use PrEP in everyday clinical practice as well as its impact on reducing HIV incidence.

These educational mini modules discuss the lessons learned from PrEP demonstration projects and open-label extension studies on approaches to mitigate potential barriers to PrEP uptake and strategies to improve integration of PrEP into existing clinical practices.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.
Review one (or all) Mini Modules of interest. Claim AMA or ANCC credit/contact hour(s) per module after completion of each brief Post-Test/Evaluation.
Kenneth Mayer
Kenneth Mayer, MD, FACP, FIDSA
Medical Research Director
Fenway Health
Professor of Medicine
Harvard Medical School
Infectious Disease Attending
Director of HIV Prevention Research
Beth Israel Deaconess Medical Center




20
Supported by an independent educational grant from
Gilead Sciences Medical Affairs
Expired Activity
Mini Module
6160
HIV